Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials

被引：1
|
作者：
Kutlar, Abdullah [1 ]
Joshi, Vikas [2 ]
Brueckner, Andreas [3 ]
Kanter, Julie [4 ]
Liles, Darla K. [5 ]
Lincy, Jeremie [3 ]
Manjare, Rahul [2 ]
Adomakoh, Yvonne Dei [6 ]
Heeney, Matthew M. [7 ]
de Montalembert, Mariane [8 ]
Keefe, Deborah [9 ]
Marfo, Kwaku [3 ]
Ataga, Kenneth I. [10 ]
机构：
[1] Med Coll Georgia, Augusta, GA USA
[2] Novartis Healthcare Private Ltd, Hyderabad, India
[3] Novartis Pharma AG, Basel, Switzerland
[4] Univ Alabama Birmingham, Birmingham, AL USA
[5] East Carolina Univ, Brody Sch Med, Greenville, NC USA
[6] Univ Ghana, Korle Bu Teaching Hosp, Med Sch, Accra, Ghana
[7] Boston Childrens Hosp, 300 Longwood Ave, Boston, MA USA
[8] Univ Paris Cite, Necker Enfants Malades Hosp, Assistance Publ Hop Paris AP HP, Paris, France
[9] Novartis Pharmaceut, E Hanover, NJ USA
[10] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188639
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Safety and efficacy profile of Trastuzumab deruxtecan in solid cancer: pooled reanalysis based on clinical trials
    Xu, Hanyue
    Zhang, Hao
    Guo, Wen
    Zhong, Xi
    Sun, Jing
    Zhang, Tao
    Wang, Zhoufeng
    Ma, Xuelei
    BMC CANCER, 2022, 22 (01)
  • [42] Safety and efficacy profile of Trastuzumab deruxtecan in solid cancer: pooled reanalysis based on clinical trials
    Hanyue Xu
    Hao Zhang
    Wen Guo
    Xi Zhong
    Jing Sun
    Tao Zhang
    Zhoufeng Wang
    Xuelei Ma
    BMC Cancer, 22
  • [43] Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: A pooled analysis of data from six clinical trials
    Winner, P
    Landy, S
    Richardson, M
    Ames, M
    CLINICAL THERAPEUTICS, 2005, 27 (11) : 1785 - 1794
  • [44] Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease
    Nichols, Kelly K.
    Donnenfeld, Eric D.
    Karpecki, Paul M.
    Hovanesian, John A.
    Raychaudhuri, Aparna
    Shojaei, Amir
    Zhang, Steven
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (04) : 394 - 401
  • [45] Infliximab safety experience: data from clinical trials in patients with psoriatic disease
    Guzzo, C.
    Gordon, K.
    Nestle, F. O.
    Li, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 417 - 417
  • [46] IN-DEPTH CHARACTERIZATION OF THE SAFETY PROFILE OF BELZUTIFAN MONOTHERAPY IN PATIENTS WITH RENAL CELL CARCINOMA: A POOLED ANALYSIS OF FOUR CLINICAL TRIALS
    Eric, Jonasch
    Pooja, Ghatalia
    Guillermo, de Velasco
    Laurence, Albiges
    Mauricio, Burotto
    Cristina, Suarez
    James, Brugarolas
    Roberto, Iacovelli
    Katriina, Jalkanen
    Elaine, T. Lam
    Ramaprasad, Srinivasan
    Jaime, Merchan
    Neeraj, Agarwal
    Ane, B. Iversen
    Brian, Rini
    Todd, M. Bauer
    Howard, Gurney
    Othon, Iliopoulos
    Lin, Jianxin
    Liis, Starkopf
    Margarita, Donica
    Olga, Gumieniak
    Donna, Vickery
    Yanfang, Liu
    Rodolfo, F. Perini
    Thomas, Powles
    Toni, K. Choueiri
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [47] Infliximab safety experience: Data from clinical trials in patients with psoriatic disease
    Gordon, KB
    Nestle, FO
    Guzzo, C
    Li, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB220 - AB220
  • [48] Infliximab safety experience: Data from clinical trials in patients with psoriatic disease
    Gordon, Kenneth B.
    Nestle, Frank O.
    Guzzo, Cynthia
    Li, Shu
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1823 - 1823
  • [49] POOLED SAFETY DATA FROM THE RISDIPLAM CLINICAL DEVELOPMENT PROGRAMME
    Baranello, Giovanni
    Servais, Laurent
    Chiriboga, Claudia
    Darras, Basil
    Bader-Weder, Silvia
    Gorni, Ksenija
    Jaber, Birgit
    McIver, Tammy
    Scalco, Renata
    Mercuri, Eugenio
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [50] Etrasimod for the treatment of ulcerative colitis: up to 2.5 years of pooled safety data from global clinical trials
    Vermeire, S.
    Peyrin-Biroulet, L.
    Panes, J.
    Regueiro, M.
    Kotze, P. G.
    Charabaty, A.
    Goetsch, M.
    Shan, K.
    Wu, J.
    McDonnell, A.
    Woolcott, J.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 619 - 619
12345